tirzepatide court decision UPDATE [March 7, 2025]: OFA takes case to appeals as legal battle evolves FDA's tirzepatide creates uncertainty – FDA confirms tirzepatide shortage is

The Wegovy pill and Zepbound have a few things in common

Arms, shoulders, hips, buttocks, and thighs

Heavily pigmented hair follicles showed strong nuclear ATM colocalisation within bulbar melanocyte nuclei

Do not use sterile water (which lacks preservative and must be used within 24 hours) or normal saline

Oct 20: Sanofi and Regeneron suffered a rare defeat with Dupixent this weekend as the FDA issued a Complete Response Letter to their supplemental Biologics License Application in chronic spontaneous urticaria, an inflammatory skin condition that leads to debilitating hives

Note: These timelines are based on glucagon pharmacology and the known titration schedule, not formally measured temperature endpoints from TRIUMPH trials